CasCure Therapeutics
Main focus: Next-generation cell therapies for autoimmune diseases
Company stage: Pre-clinical
Diseases (gene editing): Solid tumours
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: Ulsan and Seoul, Korea
Website: http://cascure.com/
CasCure Therapeutics develops a novel method to selectively target and kill cancer cells using CRISPR-Cas9 technology.